A Must-Read for Alzheimer’s Disease Researchers! Why Has pTau217 Become One of the Hottest Targets in Neuroscience?
The field of Alzheimer’s disease (AD) diagnostics has recently reached two major milestones—globally and in China—reshaping both neuroscience research and the clinical landscape.
On one hand, the Elecsys pTau217 blood test, jointly developed by Roche and Lilly, has received FDA